Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Heron Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- +10 vs. Q2 2021
- Shares held
- 108.5M
- +4.63M (+4.5%) vs. Q2 2021
- Total value
- $1.16B
- −$451.2M (−28.0%) vs. Q2 2021
- New holders
- 24
- 74 more added
- Sold out
- 14
- 45 more reduced
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 163 | $57.1M |
| Q1 2026 | 167 | $125.6M |
| Q4 2025 | 170 | $203.2M |
| Q3 2025 | 172 | $192.4M |
| Q2 2025 | 171 | $272.1M |
| Q1 2025 | 165 | $274.5M |
| Q4 2024 | 161 | $175.8M |
| Q3 2024 | 173 | $242.4M |
| Q2 2024 | 190 | $453.7M |
| Q1 2024 | 161 | $330.5M |
| Q4 2023 | 151 | $191.2M |
| Q3 2023 | 141 | $121.9M |
| Q2 2023 | 149 | $114.7M |
| Q1 2023 | 162 | $163.1M |
| Q4 2022 | 176 | $289.5M |
| Q3 2022 | 186 | $514.2M |
| Q2 2022 | 174 | $321.6M |
| Q1 2022 | 186 | $620.5M |
| Q4 2021 | 200 | $1.07B |
| Q3 2021 | 197 | $1.16B |
| Q2 2021 | 189 | $1.61B |
| Q1 2021 | 193 | $1.48B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Heron Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −176,710−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −175,333−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −129,458−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −17,296−100.0% | Sold out |
| Beirne Wealth Consulting Services, LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −10,105−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −7,721−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −6,100−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| BDO Wealth Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |
| Smith Asset Management Group LP | – | – | – | – | Not filed |